Clinical Trial Update: Expanded Access Study of UC-MSC in DMD Patients

View source ↗

Summary

Expanded Access study update for UC-MSC therapy in Duchenne Muscular Dystrophy, with the study status listed as AVAILABLE.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• UC-MSC (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: MED Institute Inc. | Conditions: Duchenne Muscular Dystrophy | Status: AVAILABLE